Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 1
2015 3
2016 3
2017 4
2018 5
2019 2
2020 5
2021 5
2022 10
2023 8
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis.
Levinsson A, Zolopa C, Vakili F, Udhesister S, Kronfli N, Maheu-Giroux M, Bruneau J, Valerio H, Bajis S, Read P, Martró E, Boucher L, Morris L, Grebely J, Artenie A, Stone J, Vickerman P, Larney S. Levinsson A, et al. Among authors: valerio h. EClinicalMedicine. 2024 Apr 10;72:102596. doi: 10.1016/j.eclinm.2024.102596. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38633576 Free PMC article.
Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study.
Valerio H, Marshall AD, Conway A, Treloar C, Carter L, Martinello M, Henderson C, Amin J, Read P, Silk D, Degenhardt L, Prain B, Alavi M, Dore GJ, Grebely J; ETHOS Engage Study Group. Valerio H, et al. Int J Drug Policy. 2024 Apr 11;127:104394. doi: 10.1016/j.drugpo.2024.104394. Online ahead of print. Int J Drug Policy. 2024. PMID: 38608357 Free article.
Corrigendum to "Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales" [JHEP Reports 4 (2022)].
Bin Usman Shah SH, Alavi M, Hajarizadeh B, Matthews GV, Martinello M, Danta M, Amin J, Law MG, George J, Valerio H, Dore GJ. Bin Usman Shah SH, et al. Among authors: valerio h. JHEP Rep. 2024 Feb 15;6(3):101022. doi: 10.1016/j.jhepr.2024.101022. eCollection 2024 Mar. JHEP Rep. 2024. PMID: 38481634 Free PMC article.
Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study.
Cheng Q, Valerio H, Cunningham EB, Shih STF, Silk D, Conway A, Treloar C, Murray C, Henderson C, Amin J, Read P, Dore GJ, Grebely J; ETHOS Engage Study Group. Cheng Q, et al. Among authors: valerio h. Value Health. 2024 Feb;27(2):216-225. doi: 10.1016/j.jval.2023.10.013. Epub 2023 Nov 10. Value Health. 2024. PMID: 37951538 Free article.
Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia: The ETHOS engage study.
Hobday S, Valerio H, Combo T, Monaghan R, Scott C, Silk D, Murray C, Read P, Henderson C, Degenhardt L, Treloar C, Dore GJ, Grebely J, Martinello M; ETHOS Engage Study Group. Hobday S, et al. Among authors: valerio h. Drug Alcohol Rev. 2023 Nov;42(7):1617-1632. doi: 10.1111/dar.13723. Epub 2023 Aug 9. Drug Alcohol Rev. 2023. PMID: 37556376 Free PMC article.
Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis.
Shih STF, Cheng Q, Carson J, Valerio H, Sheehan Y, Gray RT, Cunningham EB, Kwon JA, Lloyd AR, Dore GJ, Wiseman V, Grebely J. Shih STF, et al. Among authors: valerio h. Lancet Reg Health West Pac. 2023 Apr 4;36:100750. doi: 10.1016/j.lanwpc.2023.100750. eCollection 2023 Jul. Lancet Reg Health West Pac. 2023. PMID: 37547040 Free PMC article.
44 results